# Pipeline Activity Log

> **Review:** Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection  
> **Date:** 2026-03-06 02:53  
> **Duration:** 14m 36s  
> **Total tokens:** 130,486 (input: 88,808 / output: 41,678)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003508.pub2/full  
> **Dataset split:** HIV_test  
> **Studies:** 10  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 7 | 14m 36s | 48,965 / 12,759 |
| Librarian | 3 | 1m 31s | 11,177 / 5,368 |
| Gatekeeper | 1 | 1m 37s | 7,639 / 3,671 |
| Miner | 2 | 3m 09s | 8,337 / 7,551 |
| Critic | 2 | 2m 33s | 12,690 / 12,329 |
| **Total** | **15** | **23m 28s** | **88,808 / 41,678** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*02:55:20 — 1m 45s — 4,858 tokens*

The orchestrator reviewed the review question, objectives, background, and inclusion criteria for studies of cotrimoxazole prophylaxis in children with HIV and HIV-exposed infants. It laid out a stepwise plan to search for candidate studies, screen them against predefined eligibility rules, extract key outcomes, synthesize findings, and produce both a human-readable report and structured data. The outcome was a clear, tool-based workflow specifying populations, interventions, comparators, outcomes, and study designs to guide the next pipeline actions.

---

### 2. Orchestrator → Librarian

*02:58:42 — 3m 22s — 25,574 tokens*

The orchestrator reviewed the protocol on cotrimoxazole prophylaxis in HIV-exposed or infected children and instructed a search assistant to gather randomized and quasi-randomized trials matching the specified populations, intervention, comparators, and outcomes. It then retrieved the compiled set of candidate studies and counted them. Outcome: 10 candidate studies were identified for downstream screening.

> **Librarian — Step 1:** The librarian agent first retrieved and reviewed the systematic review protocol on cotrimoxazole prophylaxis in children with HIV to clarify the objectives, eligibility criteria, and key terms. It intended to use this information to build a comprehensive search and pull candidate studies. In this step, it only obtained and displayed the protocol; no literature search results or candidate studies were retrieved yet.
> **Librarian — Step 2:** The librarian aimed to find randomized and quasi-randomized trials of cotrimoxazole prophylaxis in HIV-infected or HIV-exposed children and relevant clinical outcomes. They crafted a broad, sensitive search using intervention synonyms, prophylaxis terms, pediatric HIV populations, trial design filters, and outcome keywords, and ran it in the literature database. The search returned 10 candidate studies, including a pediatric RCT from Zambia (CHAP) and some adult trials that will need exclusion during screening. The full search results were captured for subsequent screening and extraction.
> **Librarian — Step 3 (result):** The librarian aimed to find randomized or quasi-randomized trials of cotrimoxazole (TMP-SMX) prophylaxis in pediatric HIV populations. It ran a comprehensive Boolean search in a pre-loaded literature database using intervention, context, population, design, and outcome terms, then parsed the results to extract study titles and abstracts. It delivered a structured summary of the search strategy and provided all retrieved candidate studies for downstream screening.

---

### 3. Orchestrator → Gatekeeper

*03:00:59 — 2m 17s — 20,593 tokens*

The orchestrator advanced to the screening stage by sending the review title, objective, and verbatim selection criteria to a gatekeeper agent to judge each candidate study and provide include/exclude decisions with reasons. It then gathered the studies marked for inclusion and counted them. Outcome: 1 study met the criteria and was included.

> **Gatekeeper — Step 1 (result):** The gatekeeper screened 10 candidate studies against the protocol requiring randomized or quasi-randomized trials of routine cotrimoxazole prophylaxis versus placebo/no treatment in children with HIV or HIV-exposed infants. It evaluated each abstract and excluded studies that were adult-only, non-randomized, observational, or not prophylaxis trials. Outcome: 1 study was included (the CHAP randomized placebo-controlled trial in Zambian children) and 9 were excluded, with reasons documented for each.

---

### 4. Orchestrator → Miner

*03:04:49 — 3m 49s — 25,684 tokens*

The orchestrator initiated Step 3 (extraction) by instructing the evidence-mining agent to pull structured PICO elements and quantitative outcomes from the included studies aligned with the review objective. It requested details on population characteristics, cotrimoxazole prophylaxis specifics, comparators, key outcomes (mortality, infections, hospitalizations, adverse events, antimicrobial resistance), effect measures, follow-up timing, and study design features relevant to bias. The extraction ran to completion, with results not displayed in this log but presumably stored for subsequent steps.

> **Miner — Step 1:** The miner set out to extract structured PICO elements and outcome data from all included studies for the review. It ran a batch evidence-extraction on the single included randomized trial of cotrimoxazole prophylaxis in HIV-infected Zambian children. The extraction captured that daily cotrimoxazole reduced mortality versus placebo (hazard ratio 0.57, 95% CI 0.43–0.77; p=0.0002), with benefits consistent across ages and baseline CD4 counts and with similar overall rates of grade 3–4 adverse events during a median 19-month follow-up. These findings were prepared for integration into the final structured summary.
> **Miner — Step 2 (result):** The miner aimed to convert extracted information from the included CHAP trial into a standardized evidence record for synthesis. It compiled PICO, setting, intervention/comparator, outcomes (including hazard ratios and confidence intervals for mortality), adverse events, study design, and follow-up, marking any unavailable effect measures as not reported. The result is a finalized structured summary of the trial suitable for downstream analysis.

---

### 5. Planning (Orchestrator)

*03:05:15 — 26s — 5,189 tokens*

The orchestrator reviewed the review protocol, reaffirmed the research question and eligibility criteria, and identified the remaining tasks needed to complete the review. It laid out a stepwise plan: search for studies, prepare a clean candidate set, screen for inclusion, extract key outcomes, synthesize the evidence, format a final report, and save structured outputs. The outcome was a clear, actionable workflow with defined responsibilities for each specialized agent to complete the systematic review.

---

### 6. Orchestrator → Critic

*03:07:59 — 2m 44s — 36,684 tokens*

The orchestrator moved to the synthesis phase and instructed a reviewer agent to assess risk of bias, summarize PICO and study context, and narratively synthesize effects on primary outcomes (mortality, illness episodes including opportunistic infections like PCP), hospitalizations, and adverse events, with effect estimates and discussion of heterogeneity, applicability to low-resource settings, and potential harms. It provided the extracted evidence and review objective to guide this work. The step was marked complete, but the synthesized findings are not shown in this log.

> **Critic — Step 1:** The critic agent aimed to appraise the quality of the extracted evidence before synthesizing findings. It first isolated and validated the structured evidence from the miner, then used an evidence-quality tool to generate a scaffolded risk-of-bias and quality assessment based on the CHAP trial data. The process completed successfully, producing a structured summary of key outcomes and a framework for domain-level judgments to guide the subsequent narrative synthesis.
> **Critic — Step 2 (result):** The agent synthesized the extracted evidence to address the review question and produced a structured narrative with a study-level quality appraisal. It reviewed the single included RCT in Zambian children with HIV, concluding that cotrimoxazole prophylaxis likely reduces all-cause mortality (HR ~0.57) with a possible increase in severe neutropenia. The study was rated moderate quality with unclear overall risk of bias due to early stopping and limited reporting, and applicability was judged direct to similar resource-limited settings. Key limitations and evidence gaps (e.g., allocation concealment, hospitalization outcomes, antimicrobial resistance) were explicitly noted.

---

### 7. Final Output (Orchestrator)

*03:08:11 — 12s — 11,904 tokens*

The orchestrator compiled the final systematic review report by integrating the screening, evidence extraction, and synthesis outputs into a readable summary. It generated a report with the review title and objective, the search yield (10 candidates), screening decisions (1 included, 9 excluded), and an evidence extraction summary (including the CHAP trial). It also saved a structured evidence file and returned the formatted report as the final output.

---
